Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Failure to achieve complete resolution	1		Risk Ratio (M-H, Fixed, 95% CI)	Totals not selected
1.1 Face only	1		Risk Ratio (M-H, Fixed, 95% CI)	0.0 [0.0, 0.0]
2 Failure to achieve complete resolution (long term)	1		Risk Ratio (M-H, Fixed, 95% CI)	Totals not selected
2.1 Face only	1		Risk Ratio (M-H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3 Decrease in erythema score	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
3.1 Face only	1		Mean Difference (IV, Fixed, 95% CI)	0.0 [0.0, 0.0]
4 Decrease in erythema score (long term)	1		Mean Difference (IV, Random, 95% CI)	Totals not selected
4.1 Face only	1		Mean Difference (IV, Random, 95% CI)	0.0 [0.0, 0.0]
5 Erythema - Failure to achieve complete resolution	1		Risk Ratio (M-H, Fixed, 95% CI)	Totals not selected
5.1 Face only	1		Risk Ratio (M-H, Fixed, 95% CI)	0.0 [0.0, 0.0]
6 Decrease in scaling score	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
6.1 Face only	1		Mean Difference (IV, Fixed, 95% CI)	0.0 [0.0, 0.0]
7 Decrease in scaling score (long term)	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
7.1 Face only	1		Mean Difference (IV, Fixed, 95% CI)	0.0 [0.0, 0.0]
8 Scaling - Failure to achieve complete resolution	1		Risk Ratio (M-H, Fixed, 95% CI)	Totals not selected
8.1 Face only	1		Risk Ratio (M-H, Fixed, 95% CI)	0.0 [0.0, 0.0]
9 Side effects	1		Risk Ratio (M-H, Fixed, 95% CI)	Totals not selected
9.1 Face only	1		Risk Ratio (M-H, Fixed, 95% CI)	0.0 [0.0, 0.0]